Hematology Department

       Hematology department was founded in the 1960s. More than 40 persons work here including 16 doctors (4 chief physicians,7 associate chief physicians, 4 attending physicians, 1 resident doctor). There are 6 people getting doctor degree, 7 master degree and 3 bachelor degree of all doctors. The department has 75 ordinary beds and 5 sterile laminar beds for hematopoietic stem cell transplantation which has been divided into two units: one unit on the 22nd floor of the second hospital building (45 beds), the other unit in Caotang hospital (30 beds).

       We pay much attention to keeping track of the latest progress of diagnosis and treatment of hematology diseases and established laboratory examination system in the 1990s, such as morphology, cell differentiation antigen examination, examination of molecular genetics, molecular biology, blooding and clotting disease, which rank the top in the southwest of China. It helps us diagnose accurately in order to individualize therapy and reduce cost for patients. We have carried out autologous bone marrow transplantation, autologous peripheral blood stem cell transplantation, allogeneic hematopoietic stem cell transplantation for treatment of malignancies and some benign diseases in Sichuan province since1993 and reached the advanced level.

       The characteristics of our department: (1) allogeneic hematopoietic stem cell transplantation treatment for leukemia and other hematologic malignancies and severe aplastic anemia, and more than 30 such cases each year;(2) autologous hematopoietic stem cell transplantation for treating some acute leukemia, malignant lymphoma and myeloma, and also more than 30 cases each year, whose curative effect is superior to the traditional radiation and chemotherapy;(3) relative allogeneic peripheral blood lymphocyte infusion for some blood malignancies;(4) treatment of molecular target and immunotherapy for some blood system tumor;(5) patients with severe immunodeficiency complex with severe, infectious diseases who accept treatment on sterile laminar beds;(6) peripheral component separation technique and plasma replacement for serious and refractory disease. The near future and long-term efficacy of above treatments has reached advanced level of Sichuan province.

       We have sent young physicians abroad to learn advanced clinical and scientific research technology and there are 2 doctors who returned from Europe and the United States. We have applied for more than 20 scientific research tasks, including natural science Fund, provincial scientific and technological projects et al in recent years. There are 3 tutors who have cultivated many postgraduates. Now, 1 person is member of youth committee of hematology branch of Chinese medical association and one person is the member of hematology branch of the Chinese medical doctor association. One person is the deputy director of the hematology branch of Sichuan province medical association and 1 person is the member of the Chinese older blood tumor oncology committee. There are several doctors who are members of the hematology branch of Sichuan province medical association and the hematology branch of Chengdu medical association. More than 20 papers have been published every year including SCI and the series of Core Journal.